BioWorld

Oct. 16, 2002

View Archived Issues

Overdose Of Acetaminophen (Tylenol) Results In Hundreds Of Ruined Livers Each Year

Read More

Xerion, Arius Team Up On Effort To Develop Colon Cancer Drugs

Read More

Other News To Note

Read More

Waksal Pleads Guilty To Six Charges Related To Erbitux

Read More

Invitrogen Paying $47M In Cash For Software Provider InforMax

Invitrogen Corp. aims to create a "desktop to lab bench" tool set with its buyout of InforMax Inc. in an all-cash transaction valued at $1.36 per share, or about $42 million for the fully diluted equity. (BioWorld Today) Read More

European Officials Seek Unity To Help Challenge U.S. Position

Read More